Ottawa Hospital Research Institute

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 2001-01-01

Employees: 5K

Market Cap: -

Website: http://www.ohri.ca

Clinical Trials

The STRIVE Before Surgery Pilot Trial

Not Applicable

Active, not recruiting

Conditions: Surgery-Complications
Disability Physical

Interventions: Behavioral: Prehabilitation intervention

First Posted Date: 2023-09-18

Last Posted Date: 2024-10-15

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 144

Registration Number: NCT06042491

Locations: 🇨🇦
The Ottawa Hospital, Ottawa, Ontario, Canada

The UCAP 2 Pilot Study

Not Applicable

Withdrawn

Conditions: COPD
Asthma

Interventions: Other: Assessment and Treatment provided to participant by a respirologist using evidence-based guidelines for asthma or COPD

First Posted Date: 2023-08-28

Last Posted Date: 2024-04-25

Lead Sponsor: Ottawa Hospital Research Institute

Registration Number: NCT06014840

Locations: 🇨🇦
Ottawa Hospital General Campus, Ottawa, Ontario, Canada

Reminder Emails to Improve Pneumococcal Vaccine Completion at 12 Months of Age

Not Applicable

Recruiting

Conditions: Immunization Coverage
Pneumococcal Vaccines

Interventions: Other: Enhanced reminders
Other: Standard CANImmunize notifications

First Posted Date: 2023-08-21

Last Posted Date: 2024-04-09

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 700

Registration Number: NCT06000397

Locations: 🇨🇦
CANImmunize, Ottawa, Canada

PD-1 +/- IL-4 Inhibition in ER+ Breast Cancer

Phase 2

Not yet recruiting

Conditions: Breast Cancer

First Posted Date: 2023-08-01

Last Posted Date: 2023-08-01

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 20

Registration Number: NCT05967884

Locations: 🇨🇦
Ontario Institute for Cancer Research, Toronto, Ontario, Canada
🇨🇦
The Ottawa Hospital Research Institute and Cancer Center, Ottawa, Ontario, Canada

Umbilical Mesenchymal Stromal Cells as Cellular Immunotherapy for Septic Shock

Phase 2

Recruiting

Conditions: Septic Shock
Pathologic Processes
Shock
Sepsis
Systemic Inflammatory Response Syndrome
Inflammation
Infections

Interventions: Other: Placebo
Biological: Allogeneic umbilical cord-derived human mesenchymal stromal cells

First Posted Date: 2023-08-01

Last Posted Date: 2024-12-05

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 296

Registration Number: NCT05969275

Locations: 🇨🇦
The Ottawa Hospital (General Campus), Ottawa, Ontario, Canada
🇨🇦
The Ottawa Hospital (Civic Campus), Ottawa, Ontario, Canada

Pandemic-Proofing Simulation-based Education

Not Applicable

Not yet recruiting

Conditions: COVID 19

Interventions: Device: VR Headset
Other: Traditional Theatre-based simulation

First Posted Date: 2023-07-05

Last Posted Date: 2023-07-05

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 45

Registration Number: NCT05931679

VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy

Phase 2

Not yet recruiting

Conditions: Urologic Cancer
Venous Thromboembolism

Interventions: Other: Placebo control
Drug: Rivaroxaban 10 MG

First Posted Date: 2023-06-27

Last Posted Date: 2023-11-01

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 120

Registration Number: NCT05920343

Virtual Intervention Stroke Initiative

Not Applicable

Not yet recruiting

Conditions: Ischemic Stroke
Acute Ischemic Stroke

Interventions: Other: Virtual assessment

First Posted Date: 2023-05-25

Last Posted Date: 2024-04-04

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 80

Registration Number: NCT05875389

Clinical Trial of Vit D and Calcium for Recurrent BPPV

Not Applicable

Not yet recruiting

Conditions: Vitamin D Deficiency
Dizziness
Dizziness; Epidemic
Benign Paroxysmal Positional Vertigo
Vertigo, Peripheral
Calcium Deficiency
BPPV
Vertigo

Interventions: Dietary Supplement: vitamin D +/- calcium
Other: Placebo

First Posted Date: 2023-05-18

Last Posted Date: 2023-05-18

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 860

Registration Number: NCT05863949

High-dose Cephalexin for Cellulitis (HI-DOCC)

Phase 4

Conditions: Cellulitis

Interventions: Drug: Cephalexin

First Posted Date: 2023-05-10

Last Posted Date: 2024-06-04

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 446

Registration Number: NCT05852262

Locations: 🇨🇦
Foothills Medical Centre, Calgary, Alberta, Canada
🇨🇦
Hôpital du Sacré-Cœur de Montréal, Montréal, Quebec, Canada
🇨🇦
Kingston Health Sciences Centre, Kingston, Ontario, Canada

and more 7 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy